Craig Saxton
Directeur/Membre du Conseil chez African Medical & Research Foundation
Profil
Dr. Craig Saxton is a Member at Academy of Pharmaceutical Physicians & Investigators, a Member at Connecticut Academy of Science & Engineering, a Member at American Academy of Pharmaceutical Physicians, and a Board Member at LLC.
He is on the Board of Directors at ConjuChem Biotechnologies, Inc. and African Medical & Research Foundation.
Dr. Saxton was previously employed as Chairman by Neurogen Corp., Executive Vice President by Pfizer Global Research & Development, and Executive Vice President by Pfizer Inc. He also served on the board at inVentiv Health, Inc., ConjuChem Biotechnologies, Inc., Tularik, Inc., ConjuChem, Inc., and Veritas Medicine, Inc.
He received his undergraduate degree from the University of Leeds and a doctorate degree from the University of Leeds.
Postes actifs de Craig Saxton
| Sociétés | Poste | Début |
|---|---|---|
| Academy of Physicians In Clinical Research | Corporate Officer/Principal | - |
Connecticut Academy of Science & Engineering
 Connecticut Academy of Science & Engineering Miscellaneous Commercial ServicesCommercial Services Connecticut Academy of Science & Engineering engages in the provision of advising state government and industry in the application of science and engineering. It offers studies on public policy issues, general assembly, and private organizations. The company was founded in 1976 and is headquartered in Hartford, CT. | Corporate Officer/Principal | - |
| American Academy of Pharmaceutical Physicians | Corporate Officer/Principal | - |
| African Medical & Research Foundation | Directeur/Membre du Conseil | 13/01/2010 |
Anciens postes connus de Craig Saxton
| Sociétés | Poste | Fin |
|---|---|---|
Veritas Medicine, Inc.
 Veritas Medicine, Inc. Internet Software/ServicesTechnology Services Veritas Medicine, Inc. operates an online database of clinical trials. It offers patient enrollment solutions to determine eligibility for upcoming clinical trials. The company was founded by Robert Adelman, Joshua Schultz, and Stephen Knight in 1999 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 16/05/2011 |
inVentiv Health, Inc.
 inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Directeur/Membre du Conseil | 04/08/2010 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Président | 23/12/2009 |
ConjuChem Biotechnologies, Inc. /Old/
 ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. The company is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. ConjuChem Biotechnologies is headquartered in Montréal , Canada. | Directeur/Membre du Conseil | 31/08/2009 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 01/01/2004 |
Formation de Craig Saxton
| University of Leeds | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 14 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Veritas Medicine, Inc.
Veritas Medicine, Inc. Internet Software/ServicesTechnology Services Veritas Medicine, Inc. operates an online database of clinical trials. It offers patient enrollment solutions to determine eligibility for upcoming clinical trials. The company was founded by Robert Adelman, Joshua Schultz, and Stephen Knight in 1999 and is headquartered in Cambridge, MA. | Technology Services |
| Academy of Physicians In Clinical Research | |
Connecticut Academy of Science & Engineering
Connecticut Academy of Science & Engineering Miscellaneous Commercial ServicesCommercial Services Connecticut Academy of Science & Engineering engages in the provision of advising state government and industry in the application of science and engineering. It offers studies on public policy issues, general assembly, and private organizations. The company was founded in 1976 and is headquartered in Hartford, CT. | Commercial Services |
ConjuChem Biotechnologies, Inc. /Old/
ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. The company is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. ConjuChem Biotechnologies is headquartered in Montréal , Canada. | Health Technology |
ConjuChem, Inc.
 ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Health Technology |
| American Academy of Pharmaceutical Physicians | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
ConjuChem Biotechnologies, Inc.
 ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals. Its peptide products are used to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. ConjuChem Biotechnologies is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. The company was founded on August 25, 2009 and is headquartered in Montréal, Canada. | Health Technology |
| African Medical & Research Foundation | |
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Commercial Services |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
Decision Options LLC
 Decision Options LLC Investment ManagersFinance Decision Options LLC is a privately held, SEC-registered investment advisor and hedge fund manager headquartered in Groton, Connecticut. The firm was founded by Gill Eapen in 2001 to initially provide consultation and software for real estate valuation and portfolio management. They expanded the firm’s services to include investment advisory services for individual and institutional clients, thereafter. | Finance |
International Pharmaceuticals, Inc.
 International Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology International Pharmaceuticals, Inc. is a Filipino company that manufactures pharmaceutical products. | Health Technology |